Lanean...
Beyond The Needle: Biotech’s Delivery Challenge
Finding new ways to administer biologics could lead to higher patient acceptance and lower costs, and prove crucial as biotech companies release products aimed at more prevalent diseases. Here’s a look at the emerging world of noninjectable biologics.
Gorde:
| Egile nagusia: | |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioCommunications LLC
2004
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3564283/ https://ncbi.nlm.nih.gov/pubmed/23390391 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|